Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
GS

Gregor Schulz — 9 Patents

BABiotest Ag: 8 patents #7 of 62Top 15%
IMImmunogen: 4 patents #45 of 119Top 40%
SFScripps Clinic And Research Foundation: 1 patents #53 of 114Top 50%
Overall (All Time): #535,341 of 4,157,543Top 15%
9 Patents All Time
Gregor Schulz has been granted 9 US patents while listed as an inventor at Biotest Ag. The first was granted in 1987 and the most recent in November 2018. Gregor Schulz ranks #535,341 of 4,157,543 US inventors in our database (top 12.9%). Patent records list Gregor Schulz in Umkirch, CA, DE.

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
10117932 Uses of immunoconjugates targeting CD138 Frank Osterroth, Thomas Haeder, Christoph Bruecher, Gabriele Niemann, André Engling +7 more 2018-11-06
9995733 Agents for treating disease Frank Osterroth, Christoph Uherek, Christoph Bruecher, Benjamin Daelken, André Engling +4 more 2018-06-12
9550831 Method for treating psoriasis Silke Aigner, Matthias Germer, Frank Osterroth, Christoph Uherek, Elmar Kraus +6 more 2017-01-24
9512226 Agent for treating disease Matthias Germer, Frank Osterroth, Silke Aigner, Christoph Uherek, Elmar Kraus +6 more 2016-12-06
9387261 Immunoconjugates targeting CD138 and uses thereof Elmar Kraus, Christoph Bruecher, Benjamin Daelken, Steffen Zeng, Frank Osterroth +4 more 2016-07-12
9289509 Uses of immunoconjugates targeting CD138 Frank Osterroth, Christoph Uherek, Christoph Bruecher, Benjamin Daelken, André Engling +7 more 2016-03-22
9221914 Agents targeting CD138 and uses thereof Elmar Kraus, Christoph Bruecher, Benjamin Daelken, Matthias Germer, Steffen Zeng +3 more 2015-12-29
9011864 Method of decreasing cytotoxic side-effects and improving efficacy of immunoconjugates Christoph Bruecher, Frank Osterroth, Steffen Zeng, Christoph Uherek, Silke Aigner +3 more 2015-04-21 $7,595,000
4675287 Monoclonal antibody directed to human ganglioside GD.sub.2 Ralph A. Reisfeld 1987-06-23